{"lastName":"Ryan","objectUrn":"urn:li:member:48307020","geoRegion":"Madison, Wisconsin, United States","fullName":"Shannon Ryan","firstName":"Shannon","currentPositions":[{"companyName":"Solvias","title":"Senior Director - North American Sales ","tenureAtCompany":{"numYears":1,"numMonths":2},"companyUrnResolutionResult":{"employeeCountRange":"501-1000","headquarters":{"geographicArea":"AG","country":"Switzerland","city":"Kaiseraugst","postalCode":"4303","line1":"R\u00f6merpark 2"},"website":"http:\/\/www.solvias.com","flagshipCompanyUrl":"https:\/\/www.linkedin.com\/company\/solvias-ag\/","industry":"Pharmaceutical Manufacturing"},"startedOn":{"month":4,"year":2023},"companyUrn":"urn:li:fs_salesCompany:65591"}],"entityUrn":"urn:li:fs_salesProfile:(ACwAAALhG0wBPRPj3y4YFdaJSxe_YiCKWhs5UxI,NAME_SEARCH,vWQ-)","profilePictureDisplayImage":{"artifacts":[{"width":100,"fileIdentifyingUrlPathSegment":"100_100\/0\/1516526464840?e=1723075200&v=beta&t=wnwP890VofkGUnaxVvVJuGVcH_culVVJjOtwPJdR8lk","height":100},{"width":200,"fileIdentifyingUrlPathSegment":"200_200\/0\/1516526462323?e=1723075200&v=beta&t=fM6L4Jwd1y61ESg6hy46e9vm883K0dJe-sVrV_mjG_A","height":200},{"width":300,"fileIdentifyingUrlPathSegment":"400_400\/0\/1516526463133?e=1723075200&v=beta&t=FZ7qZnlSZqde4wjh0D5ZE20HXGiuT7Y4PWAh-PQ4kMk","height":300},{"width":300,"fileIdentifyingUrlPathSegment":"800_800\/0\/1516526462554?e=1723075200&v=beta&t=-TxNf0rclnJwvx8BubbYNB_L5ZZyWBoPMckXBV91l6I","height":300}],"rootUrl":"https:\/\/media.licdn.com\/dms\/image\/C4D03AQHlJjrJeye2Yg\/profile-displayphoto-shrink_"},"projects":[],"contactInfo":{},"industry":"Biotechnology Research","educations":[{"school":"urn:li:fs_salesSchool:163149","fieldsOfStudy":["Organic  Chemistry"],"degree":"Ph.D.","schoolUrn":"urn:li:fs_salesSchool:163149","eduId":34507097},{"school":"urn:li:fs_salesSchool:28253","fieldsOfStudy":["Chemistry\/Biology"],"degree":"BA","schoolUrn":"urn:li:fs_salesSchool:28253","eduId":34507133}],"skills":[{"numOfEndorsement":1,"name":"Polymer Chemistry"},{"numOfEndorsement":1,"name":"Peptide Synthesis"},{"numOfEndorsement":1,"name":"cGMP"},{"numOfEndorsement":4,"name":"Chemistry"},{"numOfEndorsement":15,"name":"Purification"},{"numOfEndorsement":0,"name":"Sterile filtration"},{"numOfEndorsement":1,"name":"Depth Filtration"},{"numOfEndorsement":0,"name":"Virus Filtration"},{"numOfEndorsement":0,"name":"Pharmaceutical Process Development"},{"numOfEndorsement":2,"name":"Chromatography"},{"numOfEndorsement":1,"name":"Circular Dichroism"},{"numOfEndorsement":4,"name":"Biopharmaceuticals"},{"numOfEndorsement":1,"name":"Validation"},{"numOfEndorsement":2,"name":"GMP"},{"numOfEndorsement":2,"name":"R&D"},{"numOfEndorsement":2,"name":"Pharmaceutical Industry"},{"numOfEndorsement":6,"name":"Filtration"},{"numOfEndorsement":1,"name":"HPLC"},{"numOfEndorsement":2,"name":"Protein Purification"}],"numOfConnections":798,"patents":[{"inventors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAALhG0wBPRPj3y4YFdaJSxe_YiCKWhs5UxI,NAME_SEARCH,vWQ-)"}],"description":"Baker, S.B.; Wiesmann, W.P. - Methods for making chitosan-derivative compounds and methods for controlling, inhibiting and enhancing microbial populations in a variety of environments.","title":"Chitosan-derivative Compounds and Methods of Controlling Microbial Populations","issuer":"us","issuedOn":{"month":2,"year":2015}}],"headline":"Senior Director - North American Sales, Solvias","courses":[],"certifications":[],"memberBadges":{"premium":true,"openLink":false,"jobSeeker":false},"flagshipProfileUrl":"https:\/\/www.linkedin.com\/in\/shannon-ryan-55021714","organizations":[{"name":"American Chemical Society","startedOn":{"month":2,"year":2002}}],"location":"Madison, Wisconsin, United States","publications":[{"name":"Convenient Access to Glutamic Acid Side Chain Homologs Compatible with Solid Phase Peptide Synthesis","publishedOn":{"year":2005},"description":"Ryan, S.J.; Zhang, Y, Kennan, A.J. Org. Lett., 2005, 7, 4765-4767.","publisher":"Organic Letters","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAALhG0wBPRPj3y4YFdaJSxe_YiCKWhs5UxI,NAME_SEARCH,vWQ-)"}]},{"name":"Variable Stability Heterodimeric Coiled-coils from Manipulation of Electrostatic Interface Residue Chain Length","description":"Ryan, S.J.; Kennan, A.J. JACS, 2007, 129, 10255-10260","publisher":"Journal of the American Chemical Society","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAALhG0wBPRPj3y4YFdaJSxe_YiCKWhs5UxI,NAME_SEARCH,vWQ-)"}]}],"positions":null,"posts":[{"createdAt":1715262240000,"insightId":"7269652b-2ca3-4b6d-9c0c-e673e54b7452","activityUnion":{"postActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":17},{"type":"EMPATHY","count":2}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:ugcPost:7194331465281675264","threadUrn":"urn:li:ugcPost:7194331465281675264","reactionsCount":19,"commentsCount":0,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7194331465281675264","message":{"attributes":[{"start":34,"length":22,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:431603483"}}}],"text":"Visit our booth at ASCGT and meet Kristen O'Neill, Ph.D. who gives you a quick overview below.  Thank you, Kristen!"},"rootActivity":{"contentSummaryUnion":{"mediaContentSummary":{"mediaType":"VIDEO","thumnailUrl":"https:\/\/dms.licdn.com\/playlist\/vid\/D4E05AQEsvfm0AGDZTw\/videocover-firstframe-low\/0\/1715262035633?e=1717977600&v=beta&t=hbCNEr7kf1PhHlZ0dmkCdhOquzZXEMWkg8THNzcQDoQ"}},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7194330391300722688","message":{"attributes":[{"start":13,"length":10,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:asgct2024"}}},{"start":31,"length":22,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:431603483"}}},{"start":290,"length":12,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:genetherapy"}}},{"start":303,"length":12,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:celltherapy"}}}],"text":"\ud83c\udfa5 Live from #ASGCT2024!\n\nJoin Kristen O'Neill, Ph.D. as she shares how Solvias can support cell and gene therapies developers in overcoming their biggest challenges.\n\n\ud83d\udccdVisit us at booth #2112 for an in-depth discussion and learn how Solvias can bring your innovation to its destination.\n\n#GeneTherapy #CellTherapy "},"entityUrn":"urn:li:ugcPost:7194330391300722688"},"entityUrn":"urn:li:ugcPost:7194331465281675264"}}},{"createdAt":1715100660000,"insightId":"5f37aebc-f3db-4ec0-97fe-1816c10dd0a8","activityUnion":{"postActivity":{"contentSummaryUnion":{"ingestedContentSummary":{"image":{"attributes":[{"originalImageUrl":"https:\/\/media.licdn.com\/dms\/image\/sync\/D4E27AQHjmeHG5TpKhw\/articleshare-shrink_800\/0\/1716360336931?e=1717977600&v=beta&t=LRgDflj8GQrr4GCUBCf2wci8Pclfkt8yR54eCAnlFsw","sourceType":"URL","imageUrl":"https:\/\/media.licdn.com\/dms\/image\/sync\/D4E27AQHjmeHG5TpKhw\/articleshare-shrink_800\/0\/1716360336931?e=1717977600&v=beta&t=LRgDflj8GQrr4GCUBCf2wci8Pclfkt8yR54eCAnlFsw"}]},"description":"Solvias, a global provider of CMC analytics, opens Biologics and Cell & Gene Therapy Testing Center in Research Triangle Park","fullText":"by Solvias on May 6, 2024 2:00:00 PM KAISERAUGST, Switzerland \u2013 May 6, 2024 \u2013 Solvias announced today that it is expanding its global network of laboratory testing centers with a new biotech site in Research Triangle Park, N.C. It is the company\u2019s latest investment to expand its analytical testing services supporting life science organizations with the growing number of cell and gene therapies (CGTs) and biologics in use and under development. The 50,000-square-foot facility, expected to be completed in 2025 and bring 170+ jobs to the Raleigh-Durham area, will serve as Solvias\u2019 North American hub for large molecule analytical services. It will offer critical cell-based potency assays, advanced Next-Gen Sequencing (NGS) capabilities, and related testing services supporting multiple biologic modalities. From the outset, the new testing center will support characterization and release testing of CGT and other advanced therapies, including Adeno-Associated virus (AAV) gene therapies, mRNA therapies and antibody drug conjugates. Noting that the global CGT and advanced biologics market is expected to maintain a double-digit annual growth rate over the next ten years, Archie Cullen, CEO of Solvias, said: \u201cOur new center strongly complements our biologics and CGT sites in Europe and expands our world-class testing capabilities in the U.S. Our team is thrilled to bring our newest center of excellence to Research Triangle Park, a leading research and development center and burgeoning hub for the life science industry. We will continue to invest in expanding our capabilities to support our customers with their critical work of developing and maintaining life-changing therapies.\u201d Solvias\u2019 new facility expands its global footprint to six centers of excellence. It is the company\u2019s second site in the U.S., where it supports life science organizations with analytical testing. The new center will feature state-of-the-art analytical instrumentation, laboratory automation technology and integrated digital management systems. About Solvias Solvias is a global provider of chemistry, manufacturing, and control (CMC) analytics to the life science industry. Its team of scientists combine years of experience with regulatory understanding across small molecules, biologics, and cell and gene therapies. The company offers comprehensive solutions from raw materials to drug products to final release testing, as well as API development and manufacturing for small molecules. Headquartered near Basel, Switzerland, Solvias operates six global centers of excellence to the highest standards and in accordance with ISO, GMP, GLP and FDA regulations. For more information, visit solvias.com. U.S.: Stephen Smith, General Manager U.S. stephen.smith@solvias.com M: +1 (919) 389-0377 Europe: Alexander Beck, Head of Large Molecule Services alexander.beck@solvias.com M: +41 79 722 61 92","resolvedUrl":"https:\/\/news.solvias.com\/solvias-to-build-biologics-and-cell-gene-therapy-testing-center-in-research-triangle-park","title":"Solvias to Build Biologics and Cell & Gene Therapy Testing Center in Research Triangle Park","sourceDomain":"news.solvias.com"}},"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":27},{"type":"PRAISE","count":1},{"type":"EMPATHY","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:activity:7193653657702133760","threadUrn":"urn:li:activity:7193653657702133760","reactionsCount":29,"commentsCount":0,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7193653656825573376","message":{"attributes":[{"start":26,"length":7,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:65591"}}},{"start":142,"length":24,"value":{"com.linkedin.common.HyperlinkAttributedEntity":{"url":"https:\/\/lnkd.in\/gnQY5HFR"}}},{"start":187,"length":8,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:rdd2024"}}},{"start":200,"length":6,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:ascgt"}}}],"text":"It is an exciting week at Solvias! We announced our expansion to support testing of Cell and Gene Therapy Products in Research Triangle Park (https:\/\/lnkd.in\/gnQY5HFR)  and are attending #RDD2024 and #ASCGT.   We would enjoy connecting with you at either show to share the exciting capabilities Solvias can offer to support your molecules journey!"},"entityUrn":"urn:li:share:7193653656825573376"}}},{"createdAt":1712853240000,"insightId":"77f19124-8bdb-49ea-bf23-f89e3699427c","activityUnion":{"postActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":5}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:ugcPost:7184227282348126209","threadUrn":"urn:li:ugcPost:7184227282348126209","reactionsCount":5,"commentsCount":0,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7184227282348126209","message":{"attributes":[],"text":"I have learned a lot about NGS the past few months, clearly the industry is moving away from Southern Blots for identifying integration sites.  Are you using NGS or interested in learning more?  "},"rootActivity":{"contentSummaryUnion":{"referenceContentSummary":{"entityUrn":"urn:li:poll:7184187581020930048"}},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7184187582262484992","message":{"attributes":[{"start":495,"length":4,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:ngs"}}},{"start":500,"length":12,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:celltherapy"}}},{"start":513,"length":12,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:genetherapy"}}},{"start":526,"length":10,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:cergentis"}}},{"start":537,"length":11,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:innovation"}}},{"start":549,"length":8,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:solvias"}}}],"text":"Since joining Cergentis, I've learned about the crucial importance of identifying integration sites in cell line development and cell and gene therapies. It's been nice to see many of our customers switch from traditional Southern Blots to our advanced TLA technology with NGS.\n\n\u2753 Are you still using Southern Blots, or have you moved on to NGS? \u26a1 \n\nI\u2019m curious to hear about your experiences and would love to discuss how TLA could benefit your projects.\n\nLet\u2019s connect and share insights! \ud83c\udf20 \n#NGS #CellTherapy #GeneTherapy #Cergentis #Innovation #Solvias"},"entityUrn":"urn:li:ugcPost:7184187582262484992"},"entityUrn":"urn:li:ugcPost:7184227282348126209"}}},{"createdAt":1712074140000,"insightId":"f8d5ae6f-ede4-441d-a71e-2850618a0366","activityUnion":{"postActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":12}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:ugcPost:7180959455386251264","threadUrn":"urn:li:ugcPost:7180959455386251264","reactionsCount":12,"commentsCount":0,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7180959455386251264","message":{"attributes":[{"start":30,"length":7,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:65591"}}}],"text":"I am excited to share our new Solvias website with  you.  If you are not familiar with Solvias, we are a contract research organization with world class scientists to support large and small molecule drug development, validation, and release.  Our new website showcases these capabilities so check it out or reach out to me if you are interested in learning more.  "},"rootActivity":{"contentSummaryUnion":{"mediaContentSummary":{"mediaType":"VIDEO","thumnailUrl":"https:\/\/dms.licdn.com\/playlist\/vid\/D4E10AQEZ1kzuaOu1tw\/videocover-firstframe-low\/0\/1712059212951?e=1717977600&v=beta&t=88tl4FQDXHb5HonXZWV6I1LiEedkfXbk8uHvGH9WavU"}},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7180897295930904578","message":{"attributes":[{"start":282,"length":24,"value":{"com.linkedin.common.HyperlinkAttributedEntity":{"url":"https:\/\/lnkd.in\/eh_U3sJ7"}}},{"start":308,"length":8,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:solvias"}}},{"start":317,"length":11,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:newwebsite"}}},{"start":329,"length":13,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:therapeutics"}}},{"start":343,"length":16,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:drugdevelopment"}}},{"start":360,"length":23,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:pharmaceuticalanalysis"}}}],"text":"This has been in the works for months and the launch date is finally here: Solvias' new website is live! \ud83d\udcbb\ud83c\udf89\n\nExperience a user-friendly interface, access to a wealth of resources, and explore our broad capabilities to bring your innovation to its destination.\n\n\ud83d\udd17 Visit us now at https:\/\/lnkd.in\/eh_U3sJ7\n\n#Solvias #NewWebsite #therapeutics #drugdevelopment #pharmaceuticalanalysis"},"entityUrn":"urn:li:ugcPost:7180897295930904578"},"entityUrn":"urn:li:ugcPost:7180959455386251264"}}}]}